Search for: "U.S. v. Schwartz*" Results 221 - 240 of 544
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Mar 2020, 6:33 am by Marina Chafa
By Phil Schwartz, Tom Dunlap, and Ithi Joshi [03.20.2020]   On March 18, 2020, the U.S. [read post]
12 Jan 2012, 4:50 am by Jon Hyman
Thus, even though Hosanna-Tabor Evangelical Lutheran Church & School v. [read post]
3 Jun 2011, 9:20 am by Steve Hall
The filing also cites a ruling by the U.S. 9th Circuit of Appeals — Summerlin v. [read post]
10 May 2024, 5:10 am by Andrew Lavoott Bluestone
In Pliva, Inc. v Mensing (564 U.S. 604 [2011]), the Supreme Court found that these plaintiffs’ state-law claims against generic manufacturers were preempted by federal law under the Supremacy Clause to the extent that state-law failure-to-warn statutes required generic drugs to provide more stringent, safer warning labels. [read post]
12 Aug 2016, 10:46 am by Andrew Crocker and Nate Cardozo
On its face, the claim that vulnerabilities used by the U.S. are in no danger of being used by others seems particularly weak when combined with the industry’s opposition to “exclusives,” clauses accompanying exploit purchase agreements giving the U.S. exclusive rights to their use. [read post]
2 Feb 2017, 9:26 am by Jordan Brunner
Quinta Jurecic posted the Lawfare Podcast: Goldsmith v. [read post]
11 Jul 2015, 4:56 am by Quinta Jurecic
Michael Knapp brought us news of the Second Circuit’s grant of an en banc rehearing in United States v. [read post]
8 Aug 2015, 5:47 am by Quinta Jurecic
A public comment period on the proposal is now underway, This week saw the Fourth Circuit’s decision in United States v. [read post]
30 Jun 2018, 4:08 am by Victoria Clark
  In January of 2018, Aditya Bamzai argued before the Supreme Court as an amicus curiae in Ortiz v. [read post]
30 Jul 2013, 9:01 am by WSLL
§ 3-2-107 violative of equal protection under the U.S. [read post]